Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

United States118e CongrèsS-1852Senate
Mis à jour : 6 sept. 2023

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Consulter le texte officiel

2 versions disponibles

Tous les dossiers disponibles sont affichés.

Chronologie

Dernière mesure du projet de loi complémentaire

HR-3884: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  1. Introduced in Senate

  2. Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.

    Senate

  3. Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.

    Senate

  4. Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.

    Senate